Commentary by Susan Brinkmann, OCDSIn spite of its long record of debilitating side effects for women and deadly consequences for the unborn, the FDA has relaxed guidelines for the use of the abortion drug, RU486, allowing it to be used further into pregnancy and with fewer doctor visits.
